Patents by Inventor Edward S. Willis

Edward S. Willis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for the diagnosis and prognosis of acute leukemias
    Publication number: 20030207268
    Abstract: The present invention relates to the diagnosis of the distinction between acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) and prognosis of AML. Disclosed is a means to diagnose the distinction between ALL and AML employing measurement of the abundance of the nucleic acid or protein products of small combinations (two, three or more) of particular human genes. The invention further describes the use of the measurement of the abundance of the nucleic acid or protein product of two human genes for prognostic indication in AML. The invention also relates to therapies targeted at these indicator genes, and the screening of drugs for cancer that target these indicator genes or their protein products.
    Type: Application
    Filed: August 27, 2001
    Publication date: November 6, 2003
    Inventors: Evan W. Steeg, Stephen R. Misener, Edward S. Willis, Gary E. Anderson, Roderick J. Dunne, Marc A. Lepage
  • Methods for the diagnosis and prognosis of acute leukemias
    Publication number: 20010044103
    Abstract: The present invention relates to the diagnosis of the distinction between acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) and prognosis of AML. Disclosed is a means to diagnose the distinction between ALL and AML employing measurement of the abundance of the nucleic acid or protein products of small combinations (two, three or more) of particular human genes. The invention further describes the use of the measurement of the abundance of the nucleic acid or protein product of two human genes for prognostic indication in AML. The invention also relates to therapies targeted at these indicator genes, and the screening of drugs for cancer that target these indicator genes or their protein products.
    Type: Application
    Filed: December 1, 2000
    Publication date: November 22, 2001
    Inventors: Evan W. Steeg, Stephen R. Misener, Edward S. Willis, Gary E. Anderson, Roderick J. Dunne, Marc A. Lepage